glutathione pathway to triple negative cancer GPX4 in triple-negative breast cancer: A key regulator of ferroptosis and therapeutic target Excessive glutathione intake contributes to
Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Recent advances in targeted strategies for triple negative breast cancer Journal of Hematology & Oncology Springer Nature Link
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



